ID   NCC-CDS1-X3-C1
AC   CVCL_YL55
SY   NCCCDS1X3C1
DR   DepMap; ACH-002796
DR   Wikidata; Q95992507
RX   PubMed=28680140;
WW   https://en.cellline.jp/product/ncc-cds1-x3-c1/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Characteristics: Established from a third generation xenograft established by subcutaneous injection in female NOD/Shi-scid IL-2Rgammanull mice.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo T.).
CC   Doubling time: ~30 hours (PubMed=28680140).
CC   Sequence variation: Gene fusion; HGNC; 14214; CIC + HGNC; 50800; DUX4; Name(s)=CIC-DUX4 (PubMed=28680140).
CC   Omics: Deep proteome analysis.
ST   Source(s): PubMed=28680140
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 11,12
ST   D16S539: 9,13
ST   D21S11: 30
ST   D5S818: 10,12
ST   D7S820: 12,13
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C165663; CIC-DUX4 sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YL54 ! NCC-CDS1-X1-C1
SX   Female
AG   29Y
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 30-01-24; Version: 8
//
RX   PubMed=28680140; DOI=10.1038/s41598-017-04967-0;
RA   Oyama R., Takahashi M., Yoshida A., Sakumoto M., Takai Y., Kito F.,
RA   Shiozawa K., Qiao Z.-W., Arai Y., Shibata T., Araki Y., Endo M.,
RA   Kawai A., Kondo T.;
RT   "Generation of novel patient-derived CIC-DUX4 sarcoma xenografts and
RT   cell lines.";
RL   Sci. Rep. 7:4712-4712(2017).
//